Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-27 @ 6:58 PM
Study NCT ID:
NCT01957150
Status:
COMPLETED
Last Update Posted:
2019-04-10
First Post:
2013-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-04
First Submit QC Date:
None
Study First Post Date:
2013-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-21
Results First Submit QC Date:
None
Results First Post Date:
2019-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-21
Last Update Post Date:
2019-04-10
Last Update Post Date Type:
ACTUAL